Form 8-K - Current report:
SEC Accession No. 0001193125-26-220607
Filing Date
2026-05-13
Accepted
2026-05-13 07:30:15
Documents
9
Period of Report
2026-05-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pvla-20260511.htm   iXBRL 8-K 43117
  Complete submission text file 0001193125-26-220607.txt   148326

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pvla-20260511.xsd EX-101.SCH 26040
12 EXTRACTED XBRL INSTANCE DOCUMENT pvla-20260511_htm.xml XML 4710
Mailing Address 353 W. LANCASTER AVENUE SUITE 200 WAYNE PA 19087
Business Address 353 W. LANCASTER AVENUE SUITE 200 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 26970934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)